GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » PB Ratio

Central Pharmaceuticals (DHA:CENTRALPHL) PB Ratio : 1.50 (As of May. 01, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-05-01), Central Pharmaceuticals's share price is BDT10.60. Central Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was BDT7.05. Hence, Central Pharmaceuticals's PB Ratio of today is 1.50.

The historical rank and industry rank for Central Pharmaceuticals's PB Ratio or its related term are showing as below:

DHA:CENTRALPHL' s PB Ratio Range Over the Past 10 Years
Min: 0.48   Med: 1.49   Max: 6.12
Current: 1.5

During the past 12 years, Central Pharmaceuticals's highest PB Ratio was 6.12. The lowest was 0.48. And the median was 1.49.

DHA:CENTRALPHL's PB Ratio is ranked better than
61.03% of 929 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs DHA:CENTRALPHL: 1.50

During the past 12 months, Central Pharmaceuticals's average Book Value Per Share Growth Rate was 27.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 2.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -11.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 0.60% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Central Pharmaceuticals was 130.30% per year. The lowest was -26.30% per year. And the median was 2.60% per year.

Back to Basics: PB Ratio


Central Pharmaceuticals PB Ratio Historical Data

The historical data trend for Central Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals PB Ratio Chart

Central Pharmaceuticals Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 2.02 2.20 2.22 2.57

Central Pharmaceuticals Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 3.71 4.33 2.57 1.52

Competitive Comparison of Central Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's PB Ratio falls into.


;
;

Central Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Central Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=10.60/7.052
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Central Pharmaceuticals  (DHA:CENTRALPHL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Central Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals Headlines

No Headlines